Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
Chao MaChengshan Gao

Abstract

Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome in which patients have symptoms and signs of HF with normal or near-normal left ventricular ejection fraction (LVEF ≥50%). Roughly half of all patients with HF worldwide have an LVEF ≥50% and nearly half have an LVEF <50%. Thanks to the increased scientific attention about the condition and improved characterization and diagnostic tools, the incidence of HF with reduced ejection fraction (HFrEF) dropped while that of HFpEF has increased by 45%. HFpEF has no single guideline for diagnosis or treatment, the patient population is heterogeneously and inconsistently described, and longitudinal studies are lacking. To better understand and overcome the disease, in this review, we updated the latest knowledge of HFpEF pathophysiology, introduced the existing promising diagnostic methods and treatments, and summarized its prognosis by reviewing the most recent cohort studies.

References

Jan 23, 2003·Brain : a Journal of Neurology·Tanja TaivassaloRonald G Haller
Jul 21, 2006·The New England Journal of Medicine·R Sacha BhatiaPeter P Liu
Sep 12, 2006·European Heart Journal·John G F ClelandUNKNOWN PEP-CHF Investigators
Nov 13, 2008·The New England Journal of Medicine·Barry M MassieUNKNOWN I-PRESERVE Investigators
Mar 21, 2009·Circulation. Heart Failure·Danielle M HenkelVéronique L Roger
Jun 15, 2010·Circulation. Heart Failure·Barry A BorlaugMargaret M Redfield
Sep 4, 2010·Journal of the American College of Cardiology·Barry A BorlaugMargaret M Redfield
Dec 9, 2010·European Heart Journal·Barry A Borlaug, Walter J Paulus
Feb 15, 2011·Lancet·William T AbrahamUNKNOWN CHAMPION Trial Study Group
Mar 9, 2011·Circulation·Peter H Brubaker, Dalane W Kitzman
Mar 29, 2011·Journal of Cardiac Failure·Holly S NormanNancy K Sweitzer
Apr 5, 2011·Cardiology Clinics·Barry A Borlaug, David A Kass
Aug 2, 2011·Cardiology Clinics·Barry A Borlaug, David A Kass
Aug 9, 2011·European Heart Journal·UNKNOWN Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
Feb 22, 2013·European Journal of Heart Failure·Muaz M AbudiabBarry A Borlaug
Mar 26, 2013·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Mark J HaykowskyDalane W Kitzman
Apr 24, 2013·European Journal of Heart Failure·Michelle M Y Chan, Carolyn S P Lam
Jul 3, 2013·Circulation. Heart Failure·Barry A BorlaugRichard J Rodeheffer
Apr 11, 2014·The New England Journal of Medicine·Bertram PittUNKNOWN TOPCAT Investigators
Apr 29, 2014·Journal of the American College of Cardiology·Seok-Jae HwangBarry A Borlaug
May 31, 2014·European Heart Journal·Vojtech MelenovskyBarry A Borlaug
Jun 25, 2014·Nature Reviews. Cardiology·Barry A Borlaug
Dec 3, 2014·Journal of the American College of Cardiology·Robert J MentzChristopher M O'Connor
Mar 10, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Nobuyuki Ohte, William C Little
Nov 10, 2015·The New England Journal of Medicine·Margaret M RedfieldUNKNOWN NHLBI Heart Failure Clinical Research Network
Mar 5, 2016·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·W C MeijersR A de Boer
Apr 9, 2016·Circulation. Heart Failure·Angela B S SantosAmil M Shah
May 5, 2016·Vascular Health and Risk Management·Manreet KanwarMaria Patarroyo-Aponte

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
coronary artery bypass

Software Mentioned

CHARM
TOPCAT
Preserved
Preserve

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Bharathi Upadhya, Dalane W Kitzman
© 2022 Meta ULC. All rights reserved